TRIDENT LIFELINE
|
TRIDENT LIFELINE Last 5 Year Cashflow Statement History
[Consolidated]
| Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|
| Profit Before Tax | ₹8.70 Cr | ₹6.58 Cr | ₹2.98 Cr |
| Adjustment | ₹0.12 Cr | ₹0.08 Cr | ₹0.33 Cr |
| Changes In working Capital | ₹-4.20 Cr | ₹-25 Cr | ₹-3.67 Cr |
| Cash Flow after changes in Working Capital | ₹4.61 Cr | ₹-18 Cr | ₹-0.36 Cr |
| Cash Flow from Operating Activities | ₹2.23 Cr | ₹-19 Cr | ₹-0.21 Cr |
| Cash Flow from Investing Activities | ₹-20 Cr | ₹-9.69 Cr | ₹-0.45 Cr |
| Cash Flow from Financing Activities | ₹11 Cr | ₹42 Cr | ₹0.80 Cr |
| Net Cash Inflow / Outflow | ₹-7.13 Cr | ₹14 Cr | ₹0.14 Cr |
| Opening Cash & Cash Equivalents | ₹14 Cr | ₹0.18 Cr | ₹0.01 Cr |
| Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - |
| Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - |
| Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - |
| Effect of Foreign Exchange Fluctuations | - | - | - |
| Closing Cash & Cash Equivalent | ₹6.65 Cr | ₹14 Cr | ₹0.16 Cr |
Compare Cashflow Statement of peers of TRIDENT LIFELINE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TRIDENT LIFELINE | ₹348.0 Cr | -2.9% | 3.5% | 1.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹407,791.0 Cr | 1.2% | 4.2% | -10.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹174,885.0 Cr | -0.5% | 8.9% | 10.8% | Stock Analytics | |
| CIPLA | ₹127,930.0 Cr | 0.4% | 3.7% | 8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹121,108.0 Cr | -0% | -2.1% | 6.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,164.0 Cr | 2.2% | -1.8% | -4.4% | Stock Analytics | |
TRIDENT LIFELINE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TRIDENT LIFELINE | -2.9% |
3.5% |
1.7% |
| SENSEX | 0.9% |
2.5% |
3.7% |
You may also like the below Video Courses